Teams up for development of core pharmaceutical intermediates

Dasan Medicam, a local research-oriented pharmaceutical marker, is gearing up to take on Pfizer's Lipitor.

Targeting a bigger share in the domestic statin-based drugs market, Dasan has formed a strategic alliance with Medicam Korea to develop core pharmaceutical intermediates, including atorvastin calcium, through its recent exchange of MOU between the two companies.

Atorvastain is a memb...